Increasing debt sounds like it would just increase the size of any future capital raise required, as well as making the pathway to profitability harder by adding larger interest repayments to the cash burn. It would be different if they knew how to use the borrowed money to increase profitability, but I haven't seen any evidence that they do.
They have used debt and cash previously raised to grow revenue and seek FDA approval. But growing revenue hasn't translated into increased profitability and there's no guarantee that gaining FDA approval will change anything other than allowing them to stay longer in a market that may not be profitable for them.
Self funded in 2 years did you say? Does that mean they are now saying EBITDA positive in 2026 instead of 2025?
BUB Price at posting:
13.0¢ Sentiment: Hold Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)